Apolipoprotein E, Dementia, and Cortical Deposition of B-Amyloid Protein
NEJM 333:1242-1247, 12831995., Polvikoski,T.,et al, 1995
Severe Necrotizing Cutaneous Lesions Complicating Treatment with Interferon Beta-1b
NEJM 332:1584, Sheremata,W.A.,et al, 1995
The Interferons:Biological Effects, Mechanisms of Action, and Use in Multiple Sclerosis
Ann Neurol 37:7-15, Weinstock-Guttman,B.,et al, 1995
Interferon Beta-1b in the Trtm of MS:Outcome of the Randomized Controlled Trial
IFNB Study Gr, Neurol 45:1277-12851995., , 1995
Effect of Interferon-B on Blood-Brain Barrier Disrupt Demonst by Contrast MRI in Relapsing-Remitting MS
Ann Neurol 37:611-619, Stone,L.A.,et al, 1995
The Effect of Nimodipine on Essential Tremor
Neurol 45:1523-1525, Biary,N.,et al, 1995
Human Prion Diseases
Ann Neurol 35:385-395, Prusiner,S.B.&Hsiao,K.K., 1994
Phenytoin and Ranitidine Interaction
Ann Int Med 120:892-893, Tse,C.S.T.&Iagmin,P., 1994
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
Stroke 25:2315-2328, Mayberg,M.R.,et al, 1994
Betaseron for Multiple Sclerosis:Implications for Therapeutics
Arch Neurol 51:125-128, Rudick,R., 1994
A Randomized, Double-Blind, Placebo-Controlled Trial of Nimodipine in Acute Ischemic Hemispheric Stroke
Stroke 25:1348-1353, Kaste,M.,et al, 1994
Prophylactic Neuroprotection for Cerebral Ischemia
Stroke 25:1075-1080, Fisher,M.,et al, 1994
Practice Advisory on Selection of Patients with Multiple Sclerosis for Treatment with Betaseron
Neurol 44:1537-1540, Alter,M.,et al, 1994
Are Magnetic Resonance Findings Pred of Clinical Outcome in Therapeutic Trials in MS? The Dilemma of Interferon-B
Ann Neurol 36:14-18, McDonald,W.I.,et al, 1994
Alternating Hemiplegia of Childhood:A Study of 10 Pts & Results of Flunarizine Treatment
Neurol 43:36-41, Silver,K.&Andermann,F., 1993
Clinicopath Conf
Spongiform Encephalopathy (Creutzfeldt-Jakob Disease) , with Amyloid (KURU) Plaques, Case 17-1993, N, JM 328:66,1993., 1993
Alternating Hemiplegia of Childhood
J Pediatr 122:673-679, Bourgeois,M.,et al, 1993
Interferon Beta-1b is Effective in Relapsing-Remitting MS
Clinical Results of a Placebo-Controlled Trial, IFNB MS Study Grp, Neurol 43:655-661, 64193., , 1993
Interferon Beta-1b is Effective in Relapsing Remitting MS, MRI Analysis Results of Placebo-Control Trial
Neurol 43:662-667, 6411993., Paty,D.W.,et al, 1993
Elevated Carbamazepine Levels Associated with Diltiazem Use
Neurol 42:937-938, Shaughnessy,A.F.&Mosley,M.R., 1992
The Molecular Pathogenesis of Alzheimer's Disease:Clinical Prospects
Lancet 340:1512-1515, Murphy,M., 1992
Ranitidine Pharmacokinetics and Adverse Central Nervous System Reactions
Arch Int Med 152:2325-2329, Slugg,P.H.,et al, 1992
Cortical Blindness after Nifedipine Treatment
BMJ 305:693, Morton,C.&Hickey-Dwyer,M., 1992
Clinical Trial of Nimodipine in Acute Ischemic Stroke
The American Nimodipine Study Group, Stroke 23:3-81992., , 1992
Subarachnoid Haemorrhage
Lancet 339:653-655, Van Gijn,J., 1992
Tissue Plasminogen Activator Plus Glutamate Antagonist Improves Outcome after Embolic Stroke
Arch Neurol 48:1235-1238, Zivin,J.A.&Mazzarella,V., 1991
BA4 Amyloid Protein Deposition in Brain After Head Trauma
Lancet 338:1422-1423, Roberts,G.W.,et al, 1991
The Effect of Flunarizine on Essential Tremor
Neurol 41:311-312, Biary,N.,et al, 1991
A Randomized Clinical Study of a Calcium-Entry Blocker (Lidoflzaine) in the Treatment of Comatose Survivors of Cardiac Arrest
NEJM 324:1225-1231, 1278-12801991., , 1991
Recurrent Attacks of Amaurosis Fugax Treated with Calcium Channel Blocker
Ann Neurol 30:423-425, Winterkorn,J.M.S.&Teman,A.J., 1991
Early Treatment of Ischemic Stroke with a Calcium Antagonist
Stroke 22:437-441, Rosenbaum,D.,et al, 1991
Central Nervous System Reactions to Histamine-2 Receptor Blockers
Ann Int Med 114:1027-1034, Cantu,T.G.&Korck,J.S., 1991
Nifedipine for Intractable Hiccups
Neurol 40:531-532, Lipps,D.C.,et al, 1990
Nimodipine after Resuscitation from Out-of-Hospital Ventricular Fibrillation
JAMA 264:3171-3177, Roine,R.O.,et al, 1990
Advances in Cluster Headache
Neurologic Clinics, 8:867-8901990., Mathew,N.T., 1990
Calcium Antagonists:Stroke Therapy Coming of Age
Stroke 21:494-501, Wong,M.C.W.&Haley,E.C., 1990
Gerstmann-Straussler-Scheinker Disease, I, Extending the Clinical Spectrum
Neurol 39:1446-1452, Farlow,M.R.,et al, 1989
Gerstmann-Straussler-Scheinker Disease, II, Neurofibrillary Tangles & Plaques with PrP-amyloid in an Affected Family
Neurol 39:1453-1461, Ghetti,B.,et al, 1989
Diltiazem-Induced Parkinsonism
Am J Med 87:95-96, Dick,R.S.&Barold,S.S., 1989
Amyloid A4 Protein and Its Precursor in Down's Syndrome and Alzheimer's Disease
NEJM 320:1446-1452, 1484-14861989., Rumble,B.,et al, 1989
Nifedipine in the Prophylaxis of Classic Migraine:A Crossover, Double-Masked, Placebo-Controlled Study of Headache
Neurol 39:284-286, McArthur,J.C.,et al, 1989
Effect of Nimodipine on Cerebral Infarction & Outcome after Subarachnoid Haemorrhage:British Aneurysm Nimodipine Trial
BMJ 298:636-642, Pickard,J.D.,et al, 1989
Nifedipine and Myoclonic Disorders
Nephron 51:281, Pedro-Botet,M.L.,et al, 1989
Parkinsonism, Tremor, and Depression Induced by Cinnarizine and Flunarizine
BMJ 297:722-723, Capella,D.,et al, 1988
Brain Amyloid and Alzheimer Disease
Ann Int Med 109:41-54, Vinters,H.V.,et al, 1988
Reduced Felodipine Bioavailability in Pts Taking Anticonvulsants
Lancet 2:480-482, Capewell,S.,et al, 1988
Effect of Chronic Treatment with the Calcium Antagonist Diltiazem in Duchenne Muscular Dystrophy
Neurol 38:609-613, Bertorini,T.E.,et al, 1988
Eye Pain with Nifedipine & Disturbance of Taste with Captopril
BMJ 296:1086-1088, Coulter,D.M., 1988
Tardive Dyskinesia
BMJ 296:150-151, Barnes,T.R.E., 1988
Nifedipine for Epilepsy? A Pilot Study
BMJ 296:530-531, Larkin,J.G.,et al, 1988